BCR and cancer: This fusion of the Bcr and Abl proteins is the product of reciprocal translocation between chromosomes 9 and 22 and leads to constitutively active tyrosine kinase-linked signaling, resulting in impaired DNA repair and genomic instability in cancer cells [33].